SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689375-23-000074
Filing Date
2023-11-07
Accepted
2023-11-07 07:20:22
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q trda-20230930.htm   iXBRL 10-Q 1637877
2 EX-31.1 trda-20230930x10qex311.htm EX-31.1 10884
3 EX-31.2 trda-20230930x10qex312.htm EX-31.2 10893
4 EX-32.1 trda-20230930x10qex321.htm EX-32.1 7240
  Complete submission text file 0001689375-23-000074.txt   6296900

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20230930.xsd EX-101.SCH 38948
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trda-20230930_cal.xml EX-101.CAL 64308
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trda-20230930_def.xml EX-101.DEF 152250
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20230930_lab.xml EX-101.LAB 512199
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20230930_pre.xml EX-101.PRE 325493
66 EXTRACTED XBRL INSTANCE DOCUMENT trda-20230930_htm.xml XML 753477
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40969 | Film No.: 231381554
SIC: 2834 Pharmaceutical Preparations